Regents of The University of Michigan provides administers bonds on behalf of the University. The company is headquartered in Ann Arbor, MI.

Qingdao Marine Biomedical Research Institute Co., Ltd., established on 2013-07-26, Business scope includes licensed projects:Drug Wholesale;pharmaceutical production;Drug retail;Pharmaceutical commissioned production;Health food production;Health food sales;food production;food business(Selling prepackaged food);food business(sell bulk food);food business;Production of Class II Medical Devices;Production of Class III Medical Devices;Class III medical device business;Sales of formula food for special medical purposes;Production of formula food for special medical purpose;Cosmetic production;Production of sterile equipment;Disinfection equipment sales;Inspection and testing service;Disinfectant production(Free of Hazardous Chemicals).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Medical Research and Experimental Development;Engineering and Technology Research and Experimental Development;New material technology research and development;New material technology promotion service;Production of Class I Medical Devices;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Specialty Chemicals Sales(Free of Hazardous Chemicals);Manufacturing of daily chemical products;Sales of daily chemical products;Cosmetics Wholesale;Cosmetics Retail;Disinfectant sales(Free of Hazardous Chemicals);Extraction of marine bioactive substances,purification,Synthesis technology research and development;Research and development of bio-based materials technology;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Offshore engineering design and module design and manufacturing services;Asset management services for self-owned capital investment.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Science & Technology Corp. provides scientific, technical, and engineering services. The firm Specializes in defense chemical and biological research, test and evaluation, range support services, earth and space sciences, polar technologies, aerospace engineering and information systems engineering and support. The company was founded in 1979 and is headquartered in Hampton, VA.

Microport Investment Holding Co. Ltd., part of MicroPort Scientific Corp., is a company headquartered in China that provides investment services.

Block Drug Co., Inc. manufactures denture care products, oral health care products, consumer over-the-counter medications, and professional dental products.

Shenzhen Nanyue Pharmaceutical Co., Ltd., established on 1991-08-01, Business scope includes general business items:,The licensing program is:Processing, production and operation of chemical raw materials and their preparations.80%export.

Shanghai Microport Medical (Group) Co. Ltd. develops, manufactures, and markets medical products for interventional cardiology and peripheral vascular diseases. The company’s products include cardiovascular, endovascular, neurovascular, peripheral vascular, coronary stent systems, balloon catheters, peripheral and cardiac retractors. The company’s products are used in cardiac catheter laboratories. The company was founded in 1998 and is based in Shanghai, China.

ULURU is a specialty pharmaceutical company, engages in the research, development, and commercialization of wound care and mucoadhesive film products in the United States and internationally. The company’s products are based on patented Nanoflex and OraDisc drug delivery technologies. Its products include Altrazeal, a transforming powder dressing for the treatment of various wounds, such as partial-thickness burns, donor sites, and abrasions, as well as surgical, acute, and chronic wounds; Aphthasol and Aptheal for the treatment of canker sores; OraDisc A for the treatment of oral conditions, which rely upon the use of medications formulated as gels and pastes that are applied to lesions in the mouth; and OraDisc B, a mucoadhesive disc product for the treatment and management of oral pain. The company was founded in 1987 and is based in Addison, Texas.

Pharnext is an advanced clinical-stage biopharmaceutical company founded in April 2007 by renowned scientists and entrepreneurs including Professor Daniel Cohen and collaborators, pioneers in modern genomics. The company develops new therapeutics for neurodegenerative diseases - orphan and common – where there are currently no cures and existing therapies available. Pharnext is the pioneer of a new paradigm for the discovery of medicinal drugs: PLEOTHERAPY™. The R&D approach protected by Pharnext systemizes new uses of approved drugs. It is based on network pharmacology utilizing complex and extensive genomic data to identify the thousands of molecules possibly involved in a disease. From this disease molecular network, Pharnext deduces synergistic combinations of drugs already approved but for unrelated indications. These novel therapeutics called PLEODRUG™ are then developed at new optimal doses and under new formulations. They offer several key advantages: efficacy, safety, and intellectual property including several composition of matter patents already granted. The proof of concept of the PLEOTHERAPY approach was obtained with PLEODRUG PXT3003 in Charcot-Marie-Tooth disease type 1A (CMT1A) through positive and consistent Phase 2 and Phase 3 results. PLEODRUG PXT864 generated encouraging Phase 2 data in Alzheimer’s disease. They also plan to develop the same agent in other orphan and common neurodegenerative diseases such as Parkinson’s disease and amyotrophic lateral sclerosis (ALS).

Part of Pfizer Inc., Wyeth Lederle Japan Ltd is a company headquartered in Tokyo, Japan, specializing in pharmaceutical preparations. Wyeth Corp., now a subsidiary of Pfizer Inc. acquired Wyeth Lederle Japan Ltd from Takeda Pharmaceutical Co., Ltd. on May 21, 2003.

Qingdao Haiji Bio-Pharmaceutical Co., Ltd., established on 2019-07-26, Business scope includes biotechnology,medicine,chemicals,Technology development in the high-tech field,technology transfer,Technical Services,technical consulting,Sales:chemical agent(Free of Hazardous Chemicals),Biological product(In addition to vaccines),Health Supplies,food(Carry out business activities according to the license issued by the Food and Drug Administration),medical instruments(Carry out business activities according to the license issued by the Food and Drug Administration),biology,Chemical instrument technology testing,analyze,testing service.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Shanghai Modern Pharmaceutical Preparation Engineering Research Center Co., Ltd., established on 1996-06-10, Business scope includes general items:Chinese and Western medicine preparations,Health care pharmaceutical preparations,Technology development on the application technology of pharmaceutical excipients,technical consulting,Technical Services,technology transfer;Design of preparation equipment,analyze;Pharmaceutical Raw Materials,Research on Testing Technology of Packaging Materials;Sales of preparation equipment;Own house rental.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license) licensed items:Inspection and testing service.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)

Rohto Pharmaceutical Co. Ltd. engages in the manufacture and sale of pharmaceutical products, cosmetics, and functional food items. Its products include eye drops, contact lens care, dermal medicines, skin care, internal medicines, cold remedies, test kits, and denture cleansers. Its operations are carried out through the following segments: Japan, America, Europe, Asia, and Others. The company was founded by Anmin Yamada on February 22, 1899 and is headquartered in Osaka, Japan.

Tianjin Pacific Pharmaceutical Co., Ltd., established on 1994-08-08, Business scope includes production,Sales of Chinese and Western medicine preparations(Production and sales according to the business scope stipulated in the drug production license),Owned Commercial Facility Lease;food,Cosmetic production,Sales.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Shanghai Nuojing Biotechnology Co., Ltd., established on 2018-04-11, The scope of business includes engaging in biotechnology,Technology development in the field of chemical science and technology,technical consulting,Technical Services,technology transfer,Instrumentation,Laboratory equipment and consumables,Chemical raw materials and products(Removal of hazardous chemicals,Monitor Chemicals,firecrackers,civilian explosives,precursor chemicals)promotion of,Business Consulting,marketing planning,Health Management Consulting,Computer Data Processing Services,Engaged in the import and export of goods and technology. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Pola Chemical Industry, Inc. provides cosmetic products, chemicals doranidazole, and pola cosmetics. The company is headquartered in Shinagawa-Ku, Japan.

Keyuan Pharmaceutical is a pharmaceutical company that engages in the manufacture of pharmaceuticals. Tablets, fluids, ointments, and injectables are among their offerings. Its goal is to improve people's lives by enabling them to achieve more, feel better, and live longer. They have technological machinery, skilled and motivated individuals, and management systems that can handle both quantity and quality of work. They are looking for new ways to improve their performance, raise their integrity to a level of excellence, implement their initiatives, and achieve their goals.